Mechanical versus biological isolated aortic valvular replacement after the age of 70: equivalent long-term results

Open Access
Publisher Website
Google Scholar
Abstract
Objective: In order to evaluate the long-term outcome of valvular substitutes in the elderly, we retrospectively analyzed two comparative groups of patients consecutively operated on by the same team for an isolated valvular aortic replacement using either a mechanical or a pericardial prosthesis. Methods: From 1982 to 1996, 206 patients over 70 years (mean 76.5±4.4) underwent an isolated aortic valvular replacement using either a St. Jude Medical (Group I, n=93) or a Mitroflow (Group II, n=113) prosthesis depending on the surgeon’s preference at the time of surgery. Both groups matched for the following pre-operative variables: sex ratio, type of aortic valve disease, NYHA status, cardiac rhythm, mean pulmonary arterial pressure, left ventricular end-diastolic pressure, LV-AO gradient, cardiac index and ejection fraction. Results: Given an early mortality rate of 6.4% in Group I and 4.4% in Group II (NS), follow-up (mean 4.4±3.7 years in Group I and 5.3±3.1 years in Group II) was 100% complete. Actuarial survival was 69.9±6 and 70.2±4.6% at 5 years for Group I and Group II, respectively, and 49.6±7.7 vs. 51.4±6.3% at 10 years (NS). Freedom from valve-related death was 86.5±4.8% in Group I vs. 82.7±4% in Group II at 5 years (NS) and 66.7±8.7 vs. 66.3±7% at 10 years (NS). There were no anticoagulant-related deaths or severe accidents in Group I. A secondary valvular replacement was necessary in 4 patients in Group II vs. none in Group I. Conclusion: The study shows a similar late survival in both groups, with a strikingly low incidence of anticoagulant-related deaths in this population. Given a higher rate of reoperation after biological valve replacement, the use of mechanical valve in this aging population seems to be a valid option.